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Abstract It is now generally accepted that complex
mental disorders are the results of interplay between
genetic and environmental factors. This holds out the
prospect that by studying G 9 E interplay we can explain
individual variation in vulnerability and resilience to
environmental hazards in the development of mental
disorders. Furthermore studying G 9 E findings may give
insights in neurobiological mechanisms of psychiatric
disorder and so improve individualized treatment and
potentially prevention. In this paper, we provide an over-
view of the state of field with regard to G 9 E in mental
disorders. Strategies for G 9 E research are introduced.
G 9 E findings from selected mental disorders with onset
in childhood or adolescence are reviewed [such as
depressive disorders, attention-deficit/hyperactivity disor-
der (ADHD), obesity, schizophrenia and substance use
disorders]. Early seminal studies provided evidence for
G 9 E in the pathogenesis of depression implicating
5-HTTLPR, and conduct problems implicating MAOA.
Since then G 9 E effects have been seen across a wide
range of mental disorders (e.g., ADHD, anxiety, schizo-
phrenia, substance abuse disorder) implicating a wide
range of measured genes and measured environments (e.g.,
pre-, peri- and postnatal influences of both a physical and a
social nature). To date few of these G 9 E effects have
been sufficiently replicated. Indeed meta-analyses have
raised doubts about the robustness of even the most well
studied findings. In future we need larger, sufficiently pow-
ered studies that include a detailed and sophisticated charac-
terization of both phenotype and the environmental risk.
Keywords Gene–environment interaction  Depressive
disorders  ADHD  Obesity  Schizophrenia  Substance
use disorders
Introduction
Recent progress in the development of powerful new
techniques for locating and identifying human suscepti-
bility genes and genetic variations contributing to common
diseases has created new opportunities to advance our
understanding of the etiology of mental disorders. Two
approaches, linkage and association analyses, have been
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applied to identify and study genetic effects across a
number of mental disorders. These disorders include
attention-deficit/hyperactivity disorder (ADHD), autism
spectrum disorders, mood disorders, substance use disor-
ders, schizophrenia, eating disorders, obesity, and anxiety
disorders. However, despite initial optimism, few suscep-
tibility genes (i.e., predisposing sequence variations) have
been replicated with some consistency. Even for replicated
findings the effects are very small: taking all risk genotypes
into account explains only a small fraction of the variation
in the expression of a disorder.
There are several possible explanations for this. One is
that gene–environment interactions (G 9 E) have so far
been largely ignored in the design and analyses of genetic
studies. This has hampered the detection of significant
genetic effects operating in those exposed to one environ-
ment and not another [69]. This notion is supported by the
growing body of evidence for the contribution of genetic
effects in explaining individual variability in response to all
kinds of environmental hazards [68, 82, 83]. Because of
this type of work it is nowadays generally accepted that
complex mental disorders require an understanding of the
interplay between genetic and environmental factors. This
G 9 E hypothesis is neurobiologically plausible and is
supported by a growing body of evidence (e.g., there are
formal genetic studies in its favor [51]). However, some
researchers remain skeptical and call for more robust rep-
lication of initial results [70]. Clearly much more work is
needed to establish (1) the conditions under which G 9 E
occur; and (2) the mechanisms that drive the G 9 E
effects. Why do some genetic variants have effects only in
the presence of a particular environmental exposure and/or
vice versa [64]. The article starts with an overview of the
impact as well as the limitations of G 9 E studies. In
general, this is followed by more detailed information
about G 9 E research findings in some selected mental
disorders with onset in childhood or adolescence.
The importance of gene–environment interplay
in the etiology of mental disorders
G 9 E provides a potential explanation of the individual
differences in responses to environmental influences. G 9 E
occurs when the effect of exposure to an environmental
pathogen on a person’s health is conditional on the genotype
[19]. For example, children exposed to an environment
stressor known to increase risk for a certain psychiatric
disorder (e.g., high family adversity) are at a higher risk for
that disorder if they carry particular gene variants which
renders them more susceptible to that stressor (see Fig. 1).
Alternatively children carrying a genotype known to
increase susceptibility for a specific mental disorder may
only develop that disorder if they are exposed to specific
environmental risk factors (see Fig. 2).
According to these models on the one hand, differences
in individual genetic make-up are responsible for the dif-
ferences between individuals with regard to resilience or
vulnerability to the similar environmental pathogens. On
the other hand, outcomes among individuals who do not
vary in terms of the susceptibility allele may be determined
as a function of variability in environmental exposure. In
other words, G 9 E effects index a genetically determined
liability to specific environmental influences. One example
Fig. 1 Environmental factors
only lead to a disorder in
presence of a specific genetic
make-up
Fig. 2 An individual with a
susceptible genetic make-up
will only develop a disorder if
there are additional
environmental pathogens
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with one dichotomous genotype (present or absent) of a
causative genetic mutation and one dichotomous environ-
mental exposure (exposure vs. non-exposure) is phenyl-
ketonuria (PKU) [46]. The development of PKU needs
both homozygote mutations in the causative gene encoding
phenylalanine hydroxylase, and exposure to phenylalanine
[53]. An example for a complex genetic disorder is the
alcohol flush reaction after alcohol ingestion in individuals
with a genetic variant leading to lowered activity of the
aldehyde dehydrogenase (ALDH), a variant which is
mainly observed in the Asian population [102]. Carriers of
this variant also can develop alcohol dependence after
exposure to alcohol, but they are at a much lower risk to do
so as compared to those who do not carry this variant.
G 9 E processes will necessarily be more complex if
several gene variants and types of environmental exposure
contribute to susceptibility for a disease [46], as is almost
certainly the case for mental disorders.
The frequent failures to replicate initial genetic findings
of association between genotypes and disease might be,
among other factors (such as differences in gender ratio,
ethnicity, age or comorbid conditions), caused by ignoring
simple differences with respect to exposure to relevant
environmental factors. If, for example, association has been
found in a sample with frequently exposed subjects but not
in those infrequently exposed, and exposure has not ascer-
tained, the source of non-replication will remain elusive
[69]. G 9 E studies thus might shed light into the geneti-
cally mediated effects underlying both resilience and vul-
nerability. This might help us to understand and resolve the
inconsistency in results found in classical association studies
with regard to correlations between disorders and genotypes.
G 9 E findings may also provide helpful insights into the
causal processes in pathogen to disorder pathways and
therefore shed light on the underlying mechanism of ‘‘how
an environmental factor external to the person gets under the
skin’’ to result in a mental disorder [69]. As these pathways
will vary between disorders, genes have the potential to offer
valuable clues to these disorder-specific causal mechanisms
[69]. Understanding G 9 E mechanisms may also provide
useful hints with regard to prevention of, and intervention
for, mental disorders. New findings in G 9 E may advance
the development of individual therapeutic strategies and
lead to pharmacogenetic-based therapeutic innovation [91,
94]. Moffitt et al. [69], along with others, emphasize the
importance of G 9 E and highlight the relevance of strate-
gic gene–environment research.
Limitations and pitfalls in studying G 9 E
Despite the self-evident value of the G 9 E strategy there
are several methodological challenges. There is the
possibility of overestimating effects and false positive
findings because of multiple testing and/or data dredging.
Along with difficulties in statistical power [16, 63, 107],
the susceptibility to artifacts in G 9 E research has to be
kept in mind. Statistically significant interactions are sen-
sitive to alterations in the definition and scaling of the
variables being examined: artefactual interactions can be
produced by altering scaling [68]. Another problem is how
to disentangle G 9 E from gene–environment correlations
(rGE), defined as the probability of a subject’s exposure to
an environmental pathogen resulting in the association of
measures of environmental exposure with genetic variation
[19, 87]. G 9 E may be affected by co-occurring rGE, in
which, according to Plomin et al., one can differentiate
between passive, active, and evocative rGE [76]. Passive
rGE occur because the parents pass on their genes and
provide their rearing experiences which may be genetically
influenced, e.g., parental qualities [89]. Active-evocative
rGE arise because their behavior makes people select their
environments and influences other peoples’ responses to
them [89]. Rutter and Silberg [88] viewed both, G 9 E and
rGE, as different forms of gene–environment interplay.
Furthermore, one needs to bear in mind the role of epige-
netic effects of environmental influences on gene expres-
sion or chromosomal structure and from variations in
heritability according to environmental circumstances [68,
83, 87]. For more details on methodological challenges and
statistical pitfalls see [28, 30, 37, 46–48, 64, 70, 80, 81, 85,
108]. In order to address these and other problems Moffit
et al. [68, 69] defined seven strategic steps for research into
measured G 9 E (see Table 1). More detailed information
pertaining to the strategies for careful deliberate G 9 E
hypothesis testing is summarized in [19, 68, 69, 85].
G 3 E findings for selected mental disorders with onset
in childhood and adolescence
Initial indications—seminal studies by Caspi
and Moffitt
The first molecular genetic evidence for G 9 E in child
and adolescent psychiatric conditions comes from two
classic studies by the research group of Caspi and Moffit
[18, 21]. These dealt with conduct disorder, depression and
emotional problems. The first study included 442 male
participants and demonstrated that the effect of childhood
maltreatment was moderated by a functional polymor-
phism in the gene encoding the neurotransmitter-metabo-
lizing enzyme monoamine oxidase A (MAOA) [18].
Carriers of the low-activity MAOA genotype who were
severely maltreated more often developed conduct disor-
der, antisocial personality and adult violent crime than
Eur Child Adolesc Psychiatry (2010) 19:199–210 201
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children with a high-activity MAOA genotype [18]. Several
researchers carried out studies to replicate this interaction
[38, 42, 54, 74, 112]. Despite a number of non-replications
a meta-analysis revealed an overall significant effect [54].
The second key study by this group examined
G 9 E in the pathogenesis of depression [21]. In this
prospective-longitudinal study the functional polymor-
phism 5-HTTLPR in the promoter region of the serotonin
transporter gene (SLC6A4) was found to moderate the
influence of stressful experiences occurring over a 5-year
period before onset of depression [21]. The carriers of one
or two copies of the low expressing short allele of the
5-HTTLPR exhibited more depressive symptoms, diag-
nosable depression, and suicidality following stressful life
events than individuals homozygous for the long allele
[21]. Additionally, Caspi et al. [21] detected an interaction
between 5-HTTLPR and childhood maltreatment over the
period between ages 3 to 11 years. This interaction showed
that childhood maltreatment predicted adult depression
only among individuals carrying a short allele of the
5-HTTLPR but not among individuals homozygous for the
long allele [21].
Depressive disorders
Following the striking initial findings of Caspi et al. [21]
studies have replicated the 5-HTTLPR G 9 E in depres-
sion (reviewed in [108]). There have also been a number of
failures to replicate [108]. A recent meta-analysis by
Munafo et al., however, concluded that the effects of
5-HTTPLR 9 serious life events (SLE) on risk of depres-
sion are compatible with chance findings [70], and a very
recent meta-analysis by Risch et al. including published
data from 14 studies [22–24, 33, 39, 41, 55, 59, 65, 66, 77,
101, 103, 111] yielded no evidence for an association of the
5-HTTLPR genotype alone or in interaction with stressful
life events with an elevated risk of depression [80]. In
addition, a gender-specific meta-analysis revealed no sex
dependent interaction effects [80]. The failure of these
meta-analyses to confirm the initial results of Caspi et al.
Table 1 Seven strategic steps for research into measured gene–environment interaction (Table adapted from [69])
Step 1: Consulting quantitative behavioral genetic models of the disorder
Step 2: Identifying a candidate environmental pathogen for the disorder
Considerations for selecting environmental risks for inclusion in G 9 E research on mental disorders
Disorder develops more frequently in persons exposed to the environmental pathogen compared to those not exposed
Variability in response among people exposed to the same environmental risk
Plausible effect of the environmental risk on biological systems involved in the disorder
Evidence that the putative risk is a true environmental pathogen having causal effects
Step 3: Optimizing measurement of environmental risk
Considerations for improved environmental measurement to support G 9 E research
Proximal measures of environmental pathogens
Age-specific environmental pathogens
The cumulative nature of environmental influences
Retrospective measures of environmental pathogens
Step 4: Systematic genome-wide approach or identifying candidate susceptible genes
Considerations for choosing among candidate genes as they emerge
Common polymorphic variants
Evidence of direct gene-to-disorder association
Functional significance in relation to reactivity to the environmental pathogen
Step 5: Testing for an interaction
Statistical models
Study sampling designs.
Ascertaining the validity of a G 9 E finding
Step 6: Evaluating whether a G 9 E interaction extends beyond the initially hypothesized triad of genes, environmental pathogen, and disorder
Step 7: Confirmation in independent samples
Meta-analyses
Validation of findings in G 9 E studies in experimental studies
Animal models (for example [8])
Functional brain imaging studies (for example [43])
Pharmacogenetics (for example [91, 94])
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[21] may indicate that there actually is no association.
Alternatively, sample differences in background genetic
and environmental factors could underlie the discrepant
findings [80] (see limitations). They could also be
explained by the limited comparability of replication
studies due to their highly divergent samples, study
designs, measures and analyses [80]. Thus, this inconsis-
tency might be caused by methodological differences in the
way of evaluating the presence of SLE and in different
diagnostic instruments applied in depression (structured
face-to-face interviews, questionnaires or telephone/lay
interviews, respectively) [29].
Further genes have been investigated with regard to
G 9 E and depression. In their case-only design, Drach-
mann Bukh et al. [29] detected an interaction between SLE
and the genotypes of 5-HTTLPR and BDNF Val66Met on
first episode depression. Additionally, they found no 3-way
interaction between SLE, 5-HTTLPR and BDNF Val66-
Met and no evidence for interactions between SLE and
polymorphisms in COMT, TPH1, ACE, 5-HTR2A, and
5-HTR2A, respectively, on depression. According to the
authors these results add evidence to the opinion that genes
influence the liability to depression not only by main
effects on risk but also by control of sensitivity to the
pathogenic effects of the environment [29]. This is plau-
sible as variation in the 5-HTTLPR polymorphisms may
modulate the serotonergic response to stress [108]. Further
evidence for this hypothesis also comes from fMRI studies
which show that carriers of the short allele of 5-HTTLPR
polymorphism demonstrate amygdala hyperactivity (meta-
analysis see [70]) leading to increased cortisol release [32].
There is also an initial indication that SLE and 5-HTTLPR
polymorphism interact to predict endocrine stress reactivity
in a non-clinical sample [2]. Adults homozygous for the
short allele with a significant history of SLE exhibited
markedly elevated cortisol secretions in response to the
stressor as compared to all other groups, indicating a sig-
nificant G 9 E on endocrine stress reactivity [2]. The
authors argue that a potential moderating role of HPA axis
hyper-reactivity is a premorbid risk factor that increases the
vulnerability for depression in subjects with low serotonin
transporter efficiency and a history of severe life events.
In the light of the conflicting G 9 E results with regard
to depression, very carefully designed study approaches for
testing of G 9 E hypothesis are urgently required (see
‘‘Limitations and pitfalls in studying G 9 E’’; Table 1).
Brown and Harris [17] recently outlined inconsistencies
with regard to the inclusion of different kinds of environ-
mental factors and the use of a life-course perspective,
respectively which may explain the failure of replication of
the initial study of Caspi et al. [21]. Brown and Harris
hypothesized that in the context of childhood maltreatment
the 5-HTTLPR polymorphism contributes to G 9 E via a
direct link with the perpetuation of an adult onset of
depression [17]. This is consistent with the hypothesis of
early changes in brain function associated with the poly-
morphism in the context of childhood maltreatment [17].
Attention-deficit/hyperactivity disorder (ADHD)
Molecular genetic research on ADHD has produced a
number of plausible candidate genes (e.g., Dopamine D4
receptor gene (DRD4), Dopamine D5 receptor gene
(DRD5), Dopamine transporter (DAT1) gene and Catechol
o-methyltransferase gene (COMT)]. However, effects of
gene variants identified through association studies are
small [34], and the association findings with some markers
are inconsistent across different studies (i.e., DAT1;
reviewed in Banaschweski et al., this issue [6]; [26]). This
inconsistency may be due to the moderation of genetic
effects by environmental factors that differ between sam-
ples. Thapar et al. [105] emphasized that phenotypic
complexity, as well as differences in the continuity and
changes in clinical presentation over ADHD will both be
influenced by the interplay between pre- and perinatal as
well as psychosocial, environmental and genetic risk fac-
tors. The impacts of environmental factors, such as intra-
uterine exposure to different drugs (prenatal smoke
exposure [9, 49, 57, 71], alcohol consumption during
pregnancy [15, 57]), psychosocial adversity [58], mothers’
expressed emotion (EE) [15, 78, 95, 96], severe early
deprivation [97, 99, 100], or low birth weight [57, 106],
have been studied in G 9 E investigations. Besides high-
lighting the role of the environment in modulating genetic
effects some of these studies provide evidence for a genetic
contribution to continuity of the disorder [31, 56, 92] and
the development of comorbid anti-social behavior [57, 104,
106].
Prenatal environmental exposures
A prospective study including 161 children suggested that
maternal prenatal smoking modifies the impact of the high-
risk 10-repeat (10r) DAT1 allele of the 40-bp VNTR (40
base-pair variable number of tandem repeats) polymor-
phism in the 30UTR of the DAT1 gene [49]. Symptoms of
hyperactivity, impulsivity as well as oppositional behavior
were increased among children who were homozygous for
the DAT1 10r allele, but only if those children were
exposed to prenatal maternal smoking [49]. However,
Neuman et al. [71] failed to replicate this G 9 E between
prenatal smoking exposure and the DAT1 10-repeat allele
in children with a diagnosis of ADHD, although the odds
for a DSM IV-diagnosis of ADHD was 1.8 times greater in
children whose genotype at the DAT1 30VNTR contained
the 9-repeat (9r) allele and whose mother smoked during
Eur Child Adolesc Psychiatry (2010) 19:199–210 203
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pregnancy than for twins who had neither of these risk
factors [71]. Apart from the possibility that the sample was
too small this failure to replicate may be due to defining
tobacco use in pregnancy as smoking more than 20 ciga-
rettes a day. In a longitudinal study (Mannheim Study of
Children at Risk) including 305 adolescents at age
15 years, Becker et al. [9] partly confirmed the findings of
Kahn et al. [49], indicating that male homozygous DAT1-
10r allele carriers with prenatal smoke exposure had sig-
nificantly higher symptoms of hyperactivity–impulsivity
than males from all other groups [9]. In contrast, Brookes
et al. failed to confirm the findings of Kahn et al. [49] in a
clinical sample [15, 57]. However, this group found evi-
dence for an interaction of a DAT1 risk haplotype and
maternal use of alcohol during pregnancy [15]. Langley
et al. [57] failed to replicate this finding perhaps because
they did not genotype both markers of the two marker
haplotype of DAT1. On the whole, the reported inconsis-
tencies in studies of G 9 E (e.g., for ADHD) elucidate the
urgent needs of replication studies with both accurate and
consistent measures of environmental factors and genetic
variants, respectively, and in meta-analyses [57].
Postnatal psychosocial adversity
The Mannheim Study of Risk Children also showed that
carriers of the DAT1 haplotype comprising the 6-repeat and
10-repeat alleles who grew up in greater psychosocial
adversity exhibited significantly more inattention and
higher hyperactivity–impulsivity than those with other
genotypes/haplotypes or those living in less adverse family
conditions [58]. Two recent papers provide more evidence
for the potential role of the psychosocial environment in
moderating genetic effects in ADHD. Building on previous
work highlighting the role of mothers’ expressed emotion
(EE) as a risk factor for poor outcomes in ADHD [78], the
first study [96] examined whether the effects of mothers’
EE on ADHD children, in terms of the development of
conduct and emotional problems, was moderated by
genetic variants in a large sub-sample of the IMAGE study
[15]. The results suggested that the impact of EE was
moderated by the presence of specific DAT1 and 5HTTLPR
genotypes; children who did not have the DAT1 10r/10r or
the 5HTTLPR l/l genotypes showed an effect of EE on
conduct problems. As far as emotional problems were
concerned, EE had effects only on those who carried the
DAT1 9r/9r alleles. The second study [99] was carried out
as part of the English and Romanian Adoptees (ERA)
longitudinal study [86] of the effects of severe early
deprivation on development. Previous studies highlighted a
link between institutional deprivation and symptoms of
ADHD [97, 100], but only in a sub-sample of cases. The
results showed that the risk for symptoms of ADHD
associated with early institutional deprivation was moder-
ated by the DAT1 but not the DRD4 genotypes, an effect
that was first apparent in early, and persisted through mid-
adolescence. In both studies it appeared that the genetic
make-up altered susceptibility of children to variations in
their social environment [10].
So far, most G 9 E studies have employed a candidate
gene approach. Studying environmental effects might also
be a good strategy for finding potential new genetic
markers using purely quantitative strategies such as QTL
mapping and genome wide association studies. In the first
study of this sort in ADHD, Sonuga-Barke et al. [95]
conducted a G 9 E analysis in the context of a genome-
wide association (GWA) scan of the IMAGE study (with
429,981 SNPS available) to identify novel genes whose
effects are moderated by high maternal EE. While no
G 9 E effect reached genome-wide significance, a number
of nominal significant effects were observed (P \ 0.105) in
particular interactions for the genes SLC1A1 and NRG3
represent reasonable candidates for further investigation
given their previous association with several psychiatric
illnesses.
Obesity
Obesity is a multi-factorial trait that results from a complex
interplay between genes and environment [62]. The surge
in the prevalence of obesity occurred within a short period
of time suggesting that environmental and behavioral
lifestyle factors play a strong role [1]. G 9 E is gaining
increased emphasis due to the large individual differences
in responses to the obesogenic environment—individuals
with a genetic predisposition to develop obesity will show
the greatest weight gain, whereas individuals with genetic
‘‘resistance’’ to obesity will gain little, if any, weight [1].
Environmental factors influence behavior or lifestyles that
determine energy intake or energy expenditure [13]. The
differences in individual responses to prevention and
treatment strategies, including negative energy balance due
to increased energy expenditure and decreased energy
intake, seem also to be influenced by individuals’ genetic
background [14].
There have already been numerous efforts to incorporate
genetic and/or gene–environment information into obesity
intervention and prevention [14]. Some genes have been
reported to be associated with weight loss following
intervention (e.g., lifestyle change, pharmacological/
dietary interventions, and exercise) (summary [14]). For
instance, one polymorphism (rs9939609) in the fat mass
and obesity associated gene (FTO) was found to have an
effect on the body mass index (BMI), which was replicated
in other large samples [62]. Individuals homozygous for
the risk A-allele weigh on average about 3–4 kg more and
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have a 1.6-fold increased risk of obesity as compared to those
who have not inherited a risk allele [62]. Furthermore, there
is evidence for a significant FTO genotype 9 physical
activity interaction, where the physically inactive homozy-
gous carriers of the risk A-allele had an increase in BMI as
compared to homozygous carriers of the T-allele [5]. Addi-
tionally, other FTO variants showed a significant association
with physical activity [79]. However, regarding these G 9 E
with FTO variants and physical activity the findings in dif-
ferent studies are inconsistent. This could be explained
among others by the use of different measurements of
physical activity (review [4]).
Additionally, animal models provide evidence for
interaction of genetic background and the impact of peri-
natal and early childhood environments on metabolic,
physiological and neuroendocrine functions and their
influence on the development of obesity [61]. Furthermore,
the systematic GWA study approach holds impressive
prospects for the future, provided that the lifestyle factors
dietary intake and physical activity are measured accu-
rately because erroneous self-reporting of these factors is a
well-known problem (review [4]).
Schizophrenia
The molecular genetic basis of schizophrenia has been
extensively studied. The SzGene database ([3]; http://
www.szgene.org/) provides an up-to-date ranking list of all
relevant candidate gene variants (to date in about 30
genes) based on meta-analyses of association studies.
Although, as with most complex phenotypes, it is very
likely that there may be many rare variants which con-
tribute substantially to the disorder, effect sizes of common
single variants are usually small, i.e., average summary
odds ratio rarely exceed 1.2 [3]. Evidence for an associa-
tion between environmental exposure and schizophrenia is
most solid for paternal age, migration, obstetric compli-
cations (fetal hypoxia and proxies for folate deficiency,
maternal infection, or stress during pregnancy), urbanicity,
and cannabis use, the latter two particularly in case of
exposure during development (see [44, 109] for review).
Findings from twin, adoption, and family studies generally
suggest that a synergy between genetic and environmental
factors determines psychotic symptoms and disorder, par-
ticularly for exposure to migration, urbanicity, obstetric
complications, cannabis, stress, and developmental trauma
[109] providing a broad range of potential environmental
factors for G 9 E studies. Generally, the neurobiological
mechanism driving the effects of these environmental
exposures is unclear rendering the selection of potentially
relevant genetic variants for G 9 E studies difficult.
A few promising hypotheses do exist and some have
been tested: a recent study [72] provided initial evidence
that variants in four out of 13 tested candidate genes
(AKT1, BDNF, DTNBP1 and GRM3), known to be regu-
lated by hypoxia or involved in vascular functioning in the
brain, showed nominally significant interaction with at
least one serious obstetric complication event (as a proxy
of fetal hypoxia) in 116 patient-trios. Another interesting
hypothesis related to obstetric complication is the potential
G 9 E interaction between prenatal virus exposure and
genes involved in the immune response, e.g., genes located
in the major histocompatibility complex (MHC) region
[67]. A first study examining interaction of season of birth
and risk variants in the MHC region, however, did not
provide any evidence for G 9 E [98]. Yet, it is possible
that prenatal environmental factors may also alter func-
tioning and structure of relevant genes: e.g., folate, which
is deficient prenatally in some individuals with schizo-
phrenia, is necessary for normal DNA-methylation and this
complicates the picture substantially. Thus, epigenetic
changes during neurodevelopment have to be considered.
In the study of Caspi et al. [20], the COMT Val158Met
Val allele moderated the risk of developing schizophreni-
form disorder at age 26 following cannabis use in adoles-
cence. Further, in a double-blind randomized controlled
trial [45] the COMT Val allele was associated with an
increased sensitivity to the negative cognitive effects of
cannabis in patients with psychoses. In another study [110],
the COMT Met allele increased the effect of stress on
psychotic and affective experiences in daily life in 31
patients with psychosis and cannabis use, but not in non-
psychotic cannabis users. There is evidence, derived from
animal models (review [44]), suggesting that there are
other promising genes (i.e., neuregulin 1 and the genes
regulating the dopaminergic and the GABA system) which
potentially moderate the effect of cannabis on the risk of
schizophrenia. Furthermore, variation in Neuregulin 1 was
also reported to moderate the effect of high expressed
emotion on the level of unusual thoughts in 200 patients
with schizophrenia [52].
In conclusion, relatively few G 9 E interaction studies
in schizophrenia are published to date. Promising testable
hypotheses based on epidemiological and experimental
neurobiological findings are available and need to be
examined.
Substance use disorders
Substance use disorders (SUD) are common, multi-facto-
rial disorders, which constitute the leading cause of a wide
variety of morbidity and mortality conditions. Both genetic
and environmental factors have been implicated in their
development, with heritability estimates ranging from 50 to
60% [40]. Moreover, growing evidence suggests that vul-
nerability to SUD may result from G 9 E [108]. Among
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the brain systems involved in the physiological response to
drugs of abuse, much attention has been placed on the
hypothalamic-pituitary-adrenocortical (HPA) axis. The
link between stressful experiences and substance use has
long been discussed [93], with the stress-coping model of
addiction proposing that substance use serves to regulate
stress-related negative affect. A critical role in the regula-
tion of the HPA axis pertains to the corticotropin-releasing
hormone (CRH) system, making the genes encoding the
CRH receptors (CRHR1, CRHR2) prominent candidates for
G 9 E studies. Blomeyer et al. [12] provided the first
evidence that genetic variation in CRHR1 moderated the
impact of stress on heavy drinking in adolescents. In 15-
year olds, the number of stressful life events during the past
3 years was found to be significantly related to increasing
rates of heavy drinking only among individuals homozy-
gous for the C allele of the haplotype-tagging SNP
rs1876831. Recently, Schmid et al. [90] demonstrated that
the CRHR1 gene and stressful life events interacted to
predict both drinking initiation in adolescence and pro-
gression of heavy alcohol use into young adulthood.
Findings from animal research support a role for G 9 E in
the development of excessive alcohol intake. In studies
with nonhuman primates, Barr et al. [7] revealed that the
effects of early stress on alcohol use in later life were
conditional on variation in the serotonin transporter gene,
with higher consumption only in carriers of the S allele of
5-HTTLPR. Subsequent studies in humans yielded incon-
sistent results. While Covault et al. [27] and Kaufman and
co-workers [50] found earlier and heavier alcohol use only
among carriers of the S allele following stressful life
events, Olsson et al. [75] observed a decrease in binge
drinking in risk settings with each additional copy of the S
allele. Nilsson et al. [73] reported that adolescents with
poor family relations had an increased risk of alcohol
intoxication when carrying the heterozygous LS genotype
of 5-HTTLPR. Laucht et al. [60] demonstrated that, when
exposed to high psychosocial adversity, individuals with
the LL genotype exhibited more hazardous drinking.
There are several potential reasons for these conflicting
findings. One major reason relates to the fact that substance
use and SUD represent a heterogeneous phenotype, which
may be differentiated into several subgroups (e.g., Clon-
inger’s typology of problem drinking [25]). However,
previous studies usually neglected issues of substance use
typology. An additional factor that could have contributed
to inconsistency may be the heterogeneity wide variety of
in measures of environmental adversity used in the dif-
ferent studies. While in several studies (e.g., [27]) envi-
ronmental adversity was characterized by exposure to
discrete acute events, others focused on chronic difficulties
surveyed over a period of years ([73]). However, research
on individual differences in biological reactivity to
environmental stress has highlighted the duration of a
stressor as an important determinant of the stress response.
Conclusions and implications
There is an emerging consensus that interindividual vari-
ability in an individuals response to environmental expo-
sures can be explained by genetic moderation of such
effects. This gene–environment interplay may explain the
individuals’ vulnerability and resilience to environmental
hazards in the development and expression of mental dis-
orders. In this paper, we have reviewed the current state of
the field with regard to G 9 E in a range of disorders with
childhood and adolescent onset. We highlight the progress
made to date—some candidate G 9 E processes have been
identified for each disorder and in some cases these have
been replicated. Nevertheless, these initial G 9 E findings
have to be interpreted with caution. The replication of
G 9 E findings has in general proved to be challenging—
as is also the case for replication of association findings in
classical candidate genetic studies. Furthermore, the vari-
ance explained by both genetic main effects and G 9 E
effects is invariably small. Initial G 9 E findings have
been challenged by studies using more stringent research
designs which better ensure that relations with the mea-
sured environmental variables are not influenced by other
correlated environmental variables or background common
genetic influences [36]. Furthermore, most G 9 E studies
have had only small samples which may explain why
G 9 E effects are difficult to detect and replicate [36].
Besides possible G 9 E in the pathogenesis of mental
disorders, genetic and environmental effects on the course
of a disorder during development are important to consider.
Even where G 9 E does not contribute to the initial
development of the disorder, it may have a modifying
effect on the developmental course and outcome [104].
However, up to now in genetic studies not much attention
was paid to the developmental course of a disorder. This is
especially true for G 9 E 9 Age. Thus, future studies in
mental disorders should put more emphasis on G 9 E in
the course of development (see [99]).
Despite all of these caveats and limitations the study of
G 9 E effects—although still in its infancy—offers a
number of exciting possibilities across a range of different
domains. It will surely stimulate progress in our under-
standing of the basic neuroscience on childhood onset
psychiatric problems. In future genetic research, G 9 E
studies may provide new insights into biological pathways
underlying the pathophysiology of mental disorders. It will
also play a crucial role in our growing comprehension/
investigation of vulnerability [11] and resilience [35, 84].
Longitudinal G 9 E research will be especially important
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as it can help us to better understand heterogeneity in
mental disorders. This in turn can be exploited in both the
development of new therapies and the targeting of existing
therapies. If we can overcome the methodological chal-
lenges that face G 9 E research, the new insights in bio-
logical pathways derived from the investigation of G 9 E
might provide new ways of individualized prevention and
therapeutic strategies.
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